FDA recall D-0096-2026

Lannett Company Inc. · Class II · drug

Product

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Reason for recall

Failed Dissolution Specifications

Distribution

Nationwide in the USA

Key facts

Status
Ongoing
Initiation date
2025-10-10
Report date
2025-10-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Seymour, IN, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0096-2026